Conventional teleretinal screening is effective in detecting diabetic retinopathy and diabetic macular edema, according to a study published in the European Journal of Ophthalmology. The assessment aimed to study the efficacy of conventional teleretinal screening (TS) in detecting diabetic retinopathy (DR) and diabetic macular edema (DME). Christina Y. Weng MD, MBA, and colleagues studied the accuracy of TS in detecting DR or DME compared with traditional ophthalmic screening, the impact of TS on DR screening compliance and other patient behaviors, and costeffectiveness and patient satisfaction with TS compared with traditional screening. TS showed acceptable sensitivity and good specificity in detecting DR, and the study team observed moderate to good agreement between TS and reference-standard DR grading. The researchers also found that TS positively impacted on overall DR screening compliance, even increasing it by more than 2-fold in one study. Weng and colleagues suggested that further studies exploring AI or other imaging technologies are needed to elucidate the most practical approach to teleretinal screening.